Krenik Tablet 250 Milligrams (Clonixin Lysinate)

Adult dose

○ Adults: Administer 125∼250 mg of clonixin lysinate orally per dose, 3 times daily.

This medication should be consulted with a doctor or pharmacist if taken by individuals who regularly consume more than three drinks daily, as it may cause gastrointestinal bleeding. This medication can affect the cardiovascular system and may increase the risk of severe thrombotic events such as myocardial infarction or stroke, thus individuals with cardiovascular disease or risk factors should exercise caution. It can also affect the gastrointestinal system, potentially leading to serious adverse reactions like bleeding, ulcers, or perforations in the stomach or intestines, hence elderly individuals or those with a history of gastrointestinal disease should be particularly careful. Patients with peptic ulcers, those allergic to the components of this medication, pregnant women, or those with severely impaired liver or kidney function should not take this medication. Caution is required when used in conjunction with other non-steroidal anti-inflammatory drugs, ACE inhibitors, aspirin, diuretics, lithium, methotrexate, anticoagulants, etc., as the risk of side effects may increase. Patients with a history of peptic ulcer, hypertension, heart failure, or liver or kidney impairment must consult with a doctor or pharmacist before taking this medication, and should closely monitor symptoms during treatment. Discontinue use immediately and consult healthcare professionals if symptoms such as gastrointestinal bleeding, skin rash, difficulty breathing, or liver function abnormalities occur during the use of this medication. This medication should be administered at the lowest effective dose for the shortest duration, and regular blood tests and liver and kidney function tests are necessary during long-term use. Nursing mothers are advised to stop breastfeeding or discontinue the medication as it may be excreted in breast milk. This medication should be kept out of the reach of children and should not be transferred to another container for safety.

• Gastrointestinal bleeding
• cardiovascular thromboembolic events
• myocardial infarction
• stroke
• bleeding from the stomach or intestines
• ulcers
• perforation
• nausea
• vomiting
• diarrhea

This medication may be sensitive to air and light; therefore, it should be stored in a tightly sealed container. This will help maintain the effectiveness of the medication and ensure safe use.

Appearance

Orange round film-coated tablet.

Package unit

10T/PTP, 500T/bottle